Dossier
drug discovery software
Coverage of drug discovery software in the Nexus archive.
- Pfizer is licensing an AI startup's drug discovery software to speed up antibody design
Pfizer is licensing an AI startup's drug discovery software to accelerate antibody design. The software's Chai-3 model doubles the antibody design success rate compared to its predecessor.